National Institutes of Health: Investigator Initiated Extended Clinical Trial (R01)

This opportunity uses the R01 Research Project Grant funding mechanism.

This scheme is intended to support the implementation of investigator-initiated clinical trials requiring an extended project period of 6 or 7 years. The trials can be any phase, must be hypothesis-driven, and related to the research mission of one of the participating ICs.

Consultation with IC staff is strongly encouraged prior to the submission of the clinical trial implementation application. This FOA is not intended for support of clinical trials that do not require an extended project period of 6 or 7 years.

Funding & Duration

Application budgets are not limited but need to reflect the actual needs of the proposed project. The scope of the proposed project should determine the project period of 6 or 7 years.


Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply

Submission Requirements & Due Dates

  • 4 Feb 2015  – Letter of Intent (LOI) via Grants.Gov submission portal.
  • Copy of LOI forwarded to the Research Branch ASAP.
  • 20 Feb  2015  – full applications submitted to the Research Branch for internal review.

Grants Officer: Dr Don McMaster


Further Information

This entry was posted in Funding by Award Type, Grants (Project Funds), Health & Medical Sciences, International Funding and tagged . Bookmark the permalink.

Comments are closed.